Search Results
Clinical Outcomes in Pts with Dose Reduction of Selinexor in Combination with Bortezomib, and Dex
Dose reduction of selinexor in combination with bortezomib and dexamethasone in multiple myeloma
Once Weekly Selinexor, Carfilzomib and Dexamethasone in Triple Class Refractory Multiple Myeloma
Impact of prior therapies on selinexor, bortezomib and dex in R/R MM
Myeloma & selinexor in 2020
Weekly SVd vs twice weekly Vd in pts with MM: Initial results of the phase III BOSTON study
New Directions in Treating Multiple Myeloma in the Era of Novel Agents
Selinexor: a clear role in heavily pre-treated multiple myeloma
Selinexor Combinations in Clinical Trials with Dr. Jeffrey Zonder
Selinexor, Daratumumab, and Dex in Pts with MM Previously Exposed to PIs and Imids
What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. Richardson
GEM-SELIBORDARA: selinexor plus daratumumab, bortezomib, and dexamethasone in R/R multiple myeloma
